Analyst firms · Morgan Stanley · NVO
Morgan Stanley NVO price target and rating history
Novo Nordisk A/S (NVO) · Health Care
Morgan Stanley rates Novo Nordisk A/S (NVO) Underweight with a $40 price target, as of its latest action on Sep 11, 2026. It has published 7 rating actions on NVO since April 2022, including 3 upgrades and 2 downgrades. Across 4 firms with a NVO price target in the last 12 months, the median target is $41.50. Morgan Stanley's $40 is 4% below that.
- Current rating
- Underweight
- Price target
- $40
- Median target, all firms
- $41.50
- Actions on NVO
- 7
Morgan Stanley price target on NVO
Every Morgan Stanley rating on NVO
- Sep 11, 2026
- Mar 3, 2026
- Sep 29, 2025
- Feb 12, 2025
- Jan 23, 2024
- Jul 15, 2022
- Apr 12, 2022
How other firms rate NVO
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Morgan Stanley | Underweight | $40 | Sep 11, 2026 |
| Deutsche Bank | Sell | Aug 27, 2026 | |
| Berenberg | Hold | Aug 12, 2026 | |
| Wolfe Research | Peer Perform | Mar 26, 2026 | |
| Bernstein | Underperform | $175 | Mar 18, 2026 |
| TD Cowen | Hold | $42 | Mar 10, 2026 |
| Goldman Sachs | Neutral | $41 | Mar 2, 2026 |
| Kepler Cheuvreux | Hold | Feb 24, 2026 | |
| Jefferies | Hold | Feb 12, 2026 | |
| Citigroup | Neutral | Jan 27, 2026 | |
| Argus Research | Hold | Dec 8, 2025 |
Questions about Morgan Stanley and NVO
- What is Morgan Stanley's price target for NVO?
- Morgan Stanley's latest stated price target for Novo Nordisk A/S (NVO) is $40, from its action on Sep 11, 2026.
- What is Morgan Stanley's rating on NVO?
- Morgan Stanley rates NVO Underweight, a bearish rating, as of Sep 11, 2026.
- When did Morgan Stanley last change its view on NVO?
- On Sep 11, 2026, Morgan Stanley downgrades to Underweight from Equal-Weight, price target $40.
- How does Morgan Stanley's NVO target compare with other analysts?
- Across 4 firms with a NVO price target in the last 12 months, the median target is $41.50. Morgan Stanley's $40 is 4% below that.
More NVO rating histories
All Morgan Stanley ratingsNVO news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.